They said to expect results on PODRAS human trials in the back half of 2017 and didn't produce them. So why are we supposed to believe that we'll be receiving PODRAS human trial results in the 1st half of 2018 when the company hasn't even bothered informing the market that said trials have even started.
Companies who care about their image and how their growth story is portrayed to market do everything in their power to get in front of everything they're working on behind the scenes to remove any doubts and ambiguities based on their previous track record of guidance given and ensuing actual implementation!
And the main point I'm making at this grave stage is that it's baffling beyond belief that mgmt. continues to actually prefer to keep the market guessing on whether or not they've even launched PODRAS human trials or Rexista HAP studies instead of simply announcing both material events when they actually start.
What better way to jeopardize their potential NAZ listing than keeping the market in the dark on those 2 material events...when all they had to do was announce the start dates on both if both have actually started?
News 
Market Data 
Discover 
